Andrea Varrone - Publications

Affiliations: 
Karolinska Institute, Stockholm, Sweden 
Area:
neuroimaging

146 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Varrone A, Varnäs K, Jucaite A, Cselényi Z, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Halldin C, Brown AP, Vishwanathan K, Farde L. A PET study in healthy subjects of brain exposure of C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19843776. PMID 31006308 DOI: 10.1177/0271678X19843776  1
2019 Artelsmair M, Miranda-Azpiazu P, Kingston L, Bergare J, Schou M, Varrone A, Elmore CS. Synthesis, H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 30937946 DOI: 10.1002/jlcr.3731  0.68
2019 Svedberg MM, Varnäs K, Varrone A, Mitsios N, Mulder J, Gulyás B, Beaumont V, Munoz-Sanjuan I, Zaleska MM, Schmidt CJ, Halldin C, Mrzljak L. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [F]MNI-659. Brain Research. PMID 30664847 DOI: 10.1016/j.brainres.2019.01.021  1
2018 Jakobson Mo S, Axelsson J, Jonasson L, Larsson A, Ögren MJ, Ögren M, Varrone A, Eriksson L, Bäckström D, Af Bjerkén S, Linder J, Riklund K. Dopamine transporter imaging with [F]FE-PE2I PET and [I]FP-CIT SPECT-a clinical comparison. Ejnmmi Research. 8: 100. PMID 30443684 DOI: 10.1186/s13550-018-0450-0  0.84
2018 Fazio P, Paucar M, Svenningsson P, Varrone A. Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas. Current Neurology and Neuroscience Reports. 18: 85. PMID 30291526 DOI: 10.1007/s11910-018-0890-y  0.68
2018 Varnäs K, Cselényi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, Varrone A. PET imaging of [C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30270409 DOI: 10.1007/s00259-018-4161-6  1
2018 Cairns AG, Vazquez-Romero A, Mahdi-Moein M, Åden J, Elmore CS, Takano A, Arakawa R, Varrone A, Almqvist F, Schou M. Increased brain exposure of an alpha-synuclein fibrillization modulator by utilization of an activated ester pro-drug strategy. Acs Chemical Neuroscience. PMID 29901990 DOI: 10.1021/acschemneuro.8b00236  0.96
2018 Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/s00259-018-4012-5  1
2018 Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A. Nigrostriatal dopamine transporter availability in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29436751 DOI: 10.1002/mds.27316  1
2018 Lizana H, Johansson L, Axelsson JE, Larsson Strömvall A, Ögren M, Linder J, Halldin C, Varrone A, Mo SJ. Whole-body biodistribution and dosimetry of the dopamine transporter radioligand 18F-FE-PE2I in human subjects. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29348315 DOI: 10.2967/jnumed.117.197186  1
2017 Odano I, Varrone A, Hosoya T, Sakaguchi K, Gulyás B, Padmanabhan P, Ghosh KK, Yang CT, Guenther I, Wang Z, Serrano R, Chimon NG, Halldin C. Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [18F]FE-PE2I and PET. American Journal of Nuclear Medicine and Molecular Imaging. 7: 246-254. PMID 29348979  1
2017 Schain M, Fazio P, Mrzljak L, Amini N, Al-Tawil N, Fitzer-Attas C, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A. Revisiting the Logan plot to account for non-negligible blood volume in brain tissue. Ejnmmi Research. 7: 66. PMID 28822101 DOI: 10.1186/s13550-017-0314-z  1
2017 Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S. Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data. Ejnmmi Research. 7: 58. PMID 28733954 DOI: 10.1186/s13550-017-0304-1  1
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, ... ... Varrone A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  0.36
2017 Sonni I, Ratib O, Boccardi M, Picco A, Herholz K, Nobili F, Varrone A. Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 228-242. PMID 28317651 DOI: 10.1016/j.neurobiolaging.2016.04.026  0.36
2017 Fazio P, Schain M, Mrzljak L, Amini N, Nag S, Al-Tawil N, Fitzer-Attas CJ, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: a PET study with (18)F-MNI-659 and (11)C-raclopride with correction for partial volume effect. Neuroimage. PMID 28254508 DOI: 10.1016/j.neuroimage.2017.02.047  1
2017 Forsberg A, Cervenka S, Jonsson Fagerlund M, Rasmussen LS, Zetterberg H, Erlandsson Harris H, Stridh P, Christensson E, Granström A, Schening A, Dymmel K, Knave N, Terrando N, Maze M, Borg J, ... Varrone A, et al. The immune response of the human brain to abdominal surgery. Annals of Neurology. PMID 28253549 DOI: 10.1002/ana.24909  1
2017 Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, Jonsson C, de Nijs R, Hesse S, Koulibaly PM, Akdemir UO, Koole M, Tatsch K, Varrone A. [(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. Ejnmmi Physics. 4: 8. PMID 28130765 DOI: 10.1186/s40658-017-0175-6  0.44
2017 Delnomdedieu M, Forsberg A, Ogden A, Fazio P, Yu CR, Stenkrona P, Duvvuri S, David W, Al-Tawil N, Vitolo OV, Amini N, Nag S, Halldin C, Varrone A. In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects. Neuropharmacology. PMID 28122201 DOI: 10.1016/j.neuropharm.2017.01.016  1
2016 Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, Gleyzes M, Wadel K, Buisson B, Padovan-Neto FE, Chakroborty S, Ward KM, Harms JF, Beltran J, Kwan M, ... ... Varrone A, et al. Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models. Neuron. PMID 27916455 DOI: 10.1016/j.neuron.2016.10.064  1
2016 Häggkvist J, Tóth M, Tari L, Varnäs K, Svedberg M, Forsberg A, Nag S, Dominguez C, Munoz-Sanjuan I, Bard J, Wityak J, Varrone A, Halldin C, Mrzljak L. Longitudinal microPET imaging of the zQ175 mouse model of Huntington's disease shows in vivo changes of molecular targets in the striatum and the cerebral cortex. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27856625 DOI: 10.2967/jnumed.116.180497  1
2016 Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, et al. Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27633250 DOI: 10.1007/s00259-016-3510-6  1
2016 Takano A, Varrone A, Gulyás B, Salvadori P, Gee A, Windhorst A, Vercouillie J, Bormans G, Lammertsma AA, Halldin C. Guidelines to PET measurements of the target occupancy in the brain for drug development. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27514528 DOI: 10.1007/s00259-016-3476-4  1
2016 Tiger M, Farde L, Rück C, Varrone A, Forsberg A, Lindefors N, Halldin C, Lundberg J. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. Psychiatry Research. 253: 36-42. PMID 27269199 DOI: 10.1016/j.pscychresns.2016.04.016  1
2016 Sonni I, Fazio P, Schain M, Halldin C, Svenningsson P, Farde L, Varrone A. Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson's disease patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230923 DOI: 10.2967/jnumed.115.171231  1
2016 Fazio P, Schain M, Varnäs K, Halldin C, Farde L, Varrone A. Mapping the distribution of serotonin transporter in the human brainstem with high resolution PET: Validation using post-mortem autoradiography data. Neuroimage. PMID 26994829 DOI: 10.1016/j.neuroimage.2016.03.019  1
2016 Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain, Behavior, and Immunity. PMID 26820224 DOI: 10.1016/j.bbi.2016.01.019  1
2016 Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Atay Kapucu LÖ, Svarer C, Koulibaly PM, Nobili F, Pagani M, Sabri O, Sera T, ... ... Varrone A, et al. Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26816194 DOI: 10.1007/s00259-016-3309-5  1
2016 Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LÖ, Kluge A, Ziebell M, et al. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26780619 DOI: 10.1007/s00259-015-3304-2  1
2015 Nag S, Fazio P, Lehmann L, Kettschau G, Heinrich T, Thiele A, Svedberg M, Amini N, Leesch S, Catafau A, Hannestad J, Varrone A, Halldin C. In Vivo/In Vitro Characterisation of a Novel MAO-B Inhibitor Radioligand, Fluorine-18 Labeled Deuterated Fluorodeprenyl (18F-Fluorodeprenyl-D2). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26585057 DOI: 10.2967/jnumed.115.161083  1
2015 Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26293827 DOI: 10.1007/s00259-015-3149-8  1
2015 Jucaite A, Svenningsson P, Rinne JO, Cselényi Z, Varnäs K, Johnström P, Amini N, Kirjavainen A, Helin S, Minkwitz M, Kugler AR, Posener JA, Budd S, Halldin C, Varrone A, et al. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. Brain : a Journal of Neurology. 138: 2687-700. PMID 26137956 DOI: 10.1093/brain/awv184  1
2015 Tóth M, Doorduin J, Häggkvist J, Varrone A, Amini N, Halldin C, Gulyás B. Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation. Plos One. 10: e0125917. PMID 25996996 DOI: 10.1371/journal.pone.0125917  1
2015 Varrone A, Svenningsson P, Marklund P, Fatouros-Bergman H, Forsberg A, Halldin C, Nilsson LG, Farde L. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients. Synapse (New York, N.Y.). 69: 365-74. PMID 25914348 DOI: 10.1002/syn.21823  1
2015 Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 714-20. PMID 25791993 DOI: 10.2967/jnumed.114.152421  1
2015 Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage. 112: 225-31. PMID 25772667 DOI: 10.1016/j.neuroimage.2015.03.007  1
2015 Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, et al. Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients. The Journal of Clinical Investigation. 125: 1339-46. PMID 25689258 DOI: 10.1172/JCI79635  1
2015 Finnema SJ, Hughes ZA, Haaparanta-Solin M, Stepanov V, Nakao R, Varnäs K, Varrone A, Arponen E, Marjamäki P, Pohjanoksa K, Vuorilehto L, Babalola PA, Solin O, Grimwood S, Sallinen J, et al. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522417 DOI: 10.1093/ijnp/pyu081  1
2015 Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42: 438-46. PMID 25412766 DOI: 10.1007/s00259-014-2955-8  1
2015 Tóth M, Doorduin J, Häggkvist J, Varrone A, Amini N, Halldin C, Gulyás B. Positron emission tomography studies with [11C]PBR28 in the healthy rodent brain: Validating SUV as an outcome measure of neuroinflammation Plos One. 10. DOI: 10.1371/journal.pone.0125917  1
2015 Varrone A, Lammertsma AA. Imaging of neuroinflammation: TSPO and beyond Clinical and Translational Imaging. 3: 389-390. DOI: 10.1007/s40336-015-0149-4  1
2015 Varrone A, Nordberg A. Molecular imaging of neuroinflammation in Alzheimer’s disease Clinical and Translational Imaging. 3: 437-447. DOI: 10.1007/s40336-015-0137-8  1
2014 Tóth M, Häggkvist J, Varrone A, Finnema SJ, Doorduin J, Tokunaga M, Higuchi M, Gulyás B, Halldin C. ABC transporter-dependent brain uptake of the 5-HT1B receptor radioligand [ (11)C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig. Ejnmmi Research. 4: 64. PMID 26116125 DOI: 10.1186/s13550-014-0064-0  1
2014 Nord M, Cselenyi Z, Forsberg A, Rosenqvist G, Tiger M, Lundberg J, Varrone A, Farde L. Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain. Neuroimage. 103: 303-8. PMID 25255943 DOI: 10.1016/j.neuroimage.2014.09.040  1
2014 Hesse S, van de Giessen E, Zientek F, Petroff D, Winter K, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Darcourt J, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, ... ... Varrone A, et al. Association of central serotonin transporter availability and body mass index in healthy Europeans. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1240-7. PMID 24976619 DOI: 10.1016/j.euroneuro.2014.05.005  1
2014 Tiger M, Rück C, Forsberg A, Varrone A, Lindefors N, Halldin C, Farde L, Lundberg J. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research. 223: 164-70. PMID 24916155 DOI: 10.1016/j.pscychresns.2014.05.011  1
2014 Schain M, Varnäs K, Cselényi Z, Halldin C, Farde L, Varrone A. Evaluation of two automated methods for PET region of interest analysis. Neuroinformatics. 12: 551-62. PMID 24880728 DOI: 10.1007/s12021-014-9233-6  1
2014 Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, et al. Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1938-46. PMID 24806112 DOI: 10.1007/s00259-014-2785-8  1
2014 Suzuki M, Ito H, Kodaka F, Takano H, Kimura Y, Fujiwara H, Sasaki T, Takahata K, Nogami T, Nagashima T, Nengaki N, Kawamura K, Zhang MR, Varrone A, Halldin C, et al. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans. Nuclear Medicine Communications. 35: 231-7. PMID 24468851 DOI: 10.1097/MNM.0000000000000052  1
2014 Salvatore E, Tedeschi E, Mollica C, Vicidomini C, Varrone A, Coda AR, Brunetti A, Salvatore M, De Michele G, Filla A, Pappatà S. Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 780-6. PMID 24375449 DOI: 10.1002/mds.25757  1
2014 Varrone A, Svenningsson P, Forsberg A, Varnäs K, Tiger M, Nakao R, Halldin C, Nilsson LG, Farde L. Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease. Neurobiology of Aging. 35: 867-75. PMID 24126162 DOI: 10.1016/j.neurobiolaging.2013.08.025  1
2014 Tóth M, Häggkvist J, Varrone A, Finnema SJ, Doorduin J, Tokunaga M, Higuchi M, Gulyás B, Halldin C. ABC transporter-dependent brain uptake of the 5-HT1B receptor radioligand [11C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig Ejnmmi Research. 4. DOI: 10.1186/s13550-014-0064-0  1
2013 Nag S, Lehmann L, Kettschau G, Toth M, Heinrich T, Thiele A, Varrone A, Halldin C. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B). Bioorganic & Medicinal Chemistry. 21: 6634-41. PMID 24012376 DOI: 10.1016/j.bmc.2013.08.019  1
2013 Nagy K, Tóth M, Major P, Patay G, Egri G, Häggkvist J, Varrone A, Farde L, Halldin C, Gulyás B. Performance evaluation of the small-animal nanoScan PET/MRI system. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1825-32. PMID 23990683 DOI: 10.2967/jnumed.112.119065  1
2013 McNeill A, Wu RM, Tzen KY, Aguiar PC, Arbelo JM, Barone P, Bhatia K, Barsottini O, Bonifati V, Bostantjopoulou S, Bressan R, Cossu G, Cortelli P, Felicio A, Ferraz HB, ... ... Varrone A, et al. Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis. Plos One. 8: e69190. PMID 23935950 DOI: 10.1371/journal.pone.0069190  1
2013 Thomsen G, Knudsen GM, Jensen PS, Ziebell M, Holst KK, Asenbaum S, Booij J, Darcourt J, Dickson JC, Kapucu OL, Nobili F, Sabri O, Sera T, Tatsch K, Tossici-Bolt L, ... ... Varrone A, et al. No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. Ejnmmi Research. 3: 39. PMID 23688063 DOI: 10.1186/2191-219X-3-39  1
2013 Varnäs K, Varrone A, Farde L. Modeling of PET data in CNS drug discovery and development. Journal of Pharmacokinetics and Pharmacodynamics. 40: 267-79. PMID 23660778 DOI: 10.1007/s10928-013-9320-6  1
2013 Takano A, Piehl F, Hillert J, Varrone A, Nag S, Gulyás B, Stenkrona P, Villemagne VL, Rowe CC, Macdonell R, Tawil NA, Kucinski T, Zimmermann T, Schultze-Mosgau M, Thiele A, et al. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. Ejnmmi Research. 3: 30. PMID 23618062 DOI: 10.1186/2191-219X-3-30  1
2013 Schain M, Benjaminsson S, Varnäs K, Forsberg A, Halldin C, Lansner A, Farde L, Varrone A. Arterial input function derived from pairwise correlations between PET-image voxels. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1058-65. PMID 23571279 DOI: 10.1038/jcbfm.2013.47  1
2013 Varrone A, Mattsson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, Al-Tawil N, Eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, et al. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40: 921-31. PMID 23436070 DOI: 10.1007/s00259-013-2359-1  1
2013 Ikoma Y, Takano A, Varrone A, Halldin C. Graphic plot analysis for estimating binding potential of translocator protein (TSPO) in positron emission tomography studies with [¹⁸F]FEDAA1106. Neuroimage. 69: 78-86. PMID 23247191 DOI: 10.1016/j.neuroimage.2012.12.009  1
2013 Tóth M, Varrone A, Steiger C, Laszlovszky I, Horváth A, Kiss B, Gyertyán I, Adham N, Halldin C, Gulyás B. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates. Synapse (New York, N.Y.). 67: 258-64. PMID 23238770 DOI: 10.1002/syn.21631  1
2013 Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, Ell P, Kapucu O, Kemp P, Svarer C, Varer C, Morbelli S, Pagani M, Sabri O, Tatsch K, ... ... Varrone A, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. European Journal of Nuclear Medicine and Molecular Imaging. 40: 565-73. PMID 23232506 DOI: 10.1007/s00259-012-2304-8  1
2013 Nag S, Kettschau G, Heinrich T, Varrone A, Lehmann L, Gulyas B, Thiele A, Keller É, Halldin C. Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity. Bioorganic & Medicinal Chemistry. 21: 186-95. PMID 23211968 DOI: 10.1016/j.bmc.2012.10.050  1
2013 Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Knudsen GM, Koulibaly PM, Nobili F, Pagani M, Sabri O, Vander Borght T, Van Laere K, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. European Journal of Nuclear Medicine and Molecular Imaging. 40: 213-27. PMID 23160999 DOI: 10.1007/s00259-012-2276-8  1
2013 Schain M, Tóth M, Cselényi Z, Arakawa R, Halldin C, Farde L, Varrone A. Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT. European Journal of Nuclear Medicine and Molecular Imaging. 40: 228-37. PMID 23076621 DOI: 10.1007/s00259-012-2260-3  1
2013 van de Giessen E, Hesse S, Caan MW, Zientek F, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Guignard R, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, Van Laere K, ... Varrone A, et al. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage. 64: 61-7. PMID 22982354 DOI: 10.1016/j.neuroimage.2012.09.011  1
2013 Varrone A, Halldin C. Human Brain Imaging of Dopamine Transporters Imaging of the Human Brain in Health and Disease. 203-240. DOI: 10.1016/B978-0-12-418677-4.00009-9  1
2012 Brockschnieder D, Schmitt-Willich H, Heinrich T, Varrone A, Gulyás B, Toth M, Andersson J, Boemer U, Krause S, Friebe M, Dinkelborg L, Halldin C, Dyrks T. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1794-801. PMID 23008501 DOI: 10.2967/jnumed.112.104810  1
2012 Sasaki T, Ito H, Kimura Y, Arakawa R, Takano H, Seki C, Kodaka F, Fujie S, Takahata K, Nogami T, Suzuki M, Fujiwara H, Takahashi H, Nakao R, Fukumura T, ... Varrone A, et al. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1065-73. PMID 22689927 DOI: 10.2967/jnumed.111.101626  1
2012 Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, ... ... Varrone A, et al. The relationship between cerebral vascular disease and parkinsonism: The VADO study Parkinsonism and Related Disorders. 18: 775-780. PMID 22531611 DOI: 10.1016/j.parkreldis.2012.03.017  1
2012 Farkas S, Nagy K, Jia Z, Hortobágyi T, Varrone A, Halldin C, Csiba L, Gulyás B. Signal transduction pathway activity compensates dopamine Dâ‚‚/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS. Brain Research. 1453: 56-63. PMID 22480734 DOI: 10.1016/j.brainres.2012.03.014  1
2012 Varrone A, Halldin C. New developments of dopaminergic imaging in Parkinson's disease. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 56: 68-82. PMID 22460161  1
2012 Nag S, Lehmann L, Kettschau G, Heinrich T, Thiele A, Varrone A, Gulyas B, Halldin C. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Bioorganic & Medicinal Chemistry. 20: 3065-71. PMID 22436387 DOI: 10.1016/j.bmc.2012.02.056  1
2012 Varrone A, Halldin C. New developments of dopaminergic imaging in Parkinson's disease. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 22402820  1
2012 Schain M, Tóth M, Cselényi Z, Stenkrona P, Halldin C, Farde L, Varrone A. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems. Neuroimage. 60: 800-7. PMID 22227138 DOI: 10.1016/j.neuroimage.2011.12.047  1
2012 Finnema SJ, Varrone A, Hwang TJ, Halldin C, Farde L. Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 685-95. PMID 22167236 DOI: 10.1038/jcbfm.2011.172  1
2012 Nag S, Varrone A, Tóth M, Thiele A, Kettschau G, Heinrich T, Lehmann L, Halldin C. In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligand. Synapse (New York, N.Y.). 66: 323-30. PMID 22124971 DOI: 10.1002/syn.21514  1
2012 Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, Halldin C, Farde L. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy. Neuroimage. 59: 3582-93. PMID 22056530 DOI: 10.1016/j.neuroimage.2011.10.067  1
2012 Varrone A, Gulyás B, Takano A, Stabin MG, Jonsson C, Halldin C. Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies. Nuclear Medicine and Biology. 39: 295-303. PMID 22033024 DOI: 10.1016/j.nucmedbio.2011.08.004  1
2011 Varrone A, Stepanov V, Nakao R, Tóth M, Gulyás B, Emond P, Deloye JB, Vercouillie J, Stabin MG, Jonsson C, Guilloteau D, Halldin C. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1313-21. PMID 21764797 DOI: 10.2967/jnumed.111.089953  1
2011 Takano A, Gulyás B, Varrone A, Karlsson P, Sjoholm N, Larsson S, Jonsson C, Odh R, Sparks R, Al Tawil N, Hoffmann A, Zimmermann T, Thiele A, Halldin C. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study. European Journal of Nuclear Medicine and Molecular Imaging. 38: 2058-65. PMID 21732107 DOI: 10.1007/s00259-011-1864-3  1
2011 Esmaeilzadeh M, Kullingsjö J, Ullman H, Varrone A, Tedroff J. Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease. Clinical Neuropharmacology. 34: 95-100. PMID 21586914 DOI: 10.1097/WNF.0b013e31821c31d8  1
2011 Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara MC, Jonsson C, Scheepers E, Zito F, Seese A, Koulibaly PM, Kapucu OL, Koole M, Raith M, George J, Lonsdale MN, ... ... Varrone A, et al. Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1529-40. PMID 21468761 DOI: 10.1007/s00259-011-1801-5  1
2011 Gulyás B, Vas A, Tóth M, Takano A, Varrone A, Cselényi Z, Schain M, Mattsson P, Halldin C. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Neuroimage. 56: 1111-21. PMID 21320609 DOI: 10.1016/j.neuroimage.2011.02.020  1
2011 Varrone A, Tóth M, Steiger C, Takano A, Guilloteau D, Ichise M, Gulyás B, Halldin C. Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 132-9. PMID 21189414 DOI: 10.2967/jnumed.110.077651  1
2011 Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, Tedroff J. Extrastriatal dopamine D(2) receptor binding in Huntington's disease. Human Brain Mapping. 32: 1626-36. PMID 20886576 DOI: 10.1002/hbm.21134  1
2011 Varnäs K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Söderström J, Farde L. Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 113-23. PMID 20424633 DOI: 10.1038/jcbfm.2010.55  1
2010 Varrone A, Halldin C. Molecular imaging of the dopamine transporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1331-4. PMID 20720060 DOI: 10.2967/jnumed.109.065656  1
2010 Pappatà S, Varrone A, Vicidomini C, Milan G, De Falco C, Sansone V, Iavarone A, Comerci M, Loré E, Panico MR, Quarantelli M, Postiglione A, Salvatore M. SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1156-63. PMID 20306034 DOI: 10.1007/s00259-010-1409-1  1
2010 Finnema SJ, Varrone A, Hwang TJ, Gulyás B, Pierson ME, Halldin C, Farde L. Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain. Synapse (New York, N.Y.). 64: 573-7. PMID 20222157 DOI: 10.1002/syn.20780  1
2010 Cervenka S, Varrone A, Fransén E, Halldin C, Farde L. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans. Synapse (New York, N.Y.). 64: 478-85. PMID 20175222 DOI: 10.1002/syn.20765  1
2010 Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, Walker Z, NÃ¥gren K, Tatsch K, Darcourt J. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 37: 434-42. PMID 19838704 DOI: 10.1007/s00259-009-1265-z  1
2010 Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, NÃ¥gren K, Nobili F, Walker Z, Van Laere K. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 37: 443-50. PMID 19838702 DOI: 10.1007/s00259-009-1267-x  1
2010 Dickson JC, Tossici-Bolt L, Sera T, Erlandsson K, Varrone A, Tatsch K, Hutton BF. The impact of reconstruction method on the quantification of DaTSCAN images. European Journal of Nuclear Medicine and Molecular Imaging. 37: 23-35. PMID 19618181 DOI: 10.1007/s00259-009-1212-z  1
2009 Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, NÃ¥gren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 36: 2103-10. PMID 19838705 DOI: 10.1007/s00259-009-1264-0  1
2009 Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, NÃ¥gren K, Darcourt J, Tatsch K, Van Laere KJ. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 36: 2093-102. PMID 19838703 DOI: 10.1007/s00259-009-1266-y  1
2009 Schou M, Steiger C, Varrone A, Guilloteau D, Halldin C. Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 19: 4843-5. PMID 19577467 DOI: 10.1016/j.bmcl.2009.06.032  1
2009 Takano A, Gulyás B, Varrone A, Halldin C. Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1885-91. PMID 19565240 DOI: 10.1007/s00259-009-1194-x  1
2009 Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyás B, Halldin C. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse (New York, N.Y.). 63: 871-80. PMID 19562698 DOI: 10.1002/syn.20670  1
2009 Varrone A, Sjöholm N, Eriksson L, Gulyás B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1639-50. PMID 19437012 DOI: 10.1007/s00259-009-1156-3  1
2009 Takano A, Gulyás B, Varrone A, Maguire RP, Halldin C. Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2). European Journal of Nuclear Medicine and Molecular Imaging. 36: 1308-14. PMID 19300997 DOI: 10.1007/s00259-009-1118-9  1
2009 McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, Klingberg T. Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science (New York, N.Y.). 323: 800-2. PMID 19197069 DOI: 10.1126/science.1166102  1
2009 Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L. [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil. Neuroimage. 45: 891-902. PMID 19136064 DOI: 10.1016/j.neuroimage.2008.12.005  1
2009 Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K, Varrone A, Vicidomini C, Picillo M, De Michele G, Filla A, Salvatore M, Pappatà S. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 689-96. PMID 19117367 DOI: 10.1002/mds.22440  1
2009 Amboni M, Pellecchia MT, Cozzolino A, Picillo M, Vitale C, Barone P, Varrone A, Garavaglia B, Gambelli S, Federico A. Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 303-5. PMID 18973255 DOI: 10.1002/mds.22342  1
2008 Takano A, Varrone A, Gulyás B, Karlsson P, Tauscher J, Halldin C. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2. Neuroimage. 42: 474-82. PMID 18617423 DOI: 10.1016/j.neuroimage.2008.05.040  1
2008 Varrone A, Sansone V, Pellecchia MT, Amboni M, Salvatore E, De Michele G, Filla A, Barone P, Pappatà S, Salvatore M. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1343-9. PMID 18283454 DOI: 10.1007/s00259-008-0729-x  1
2008 Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordström AL. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage. 39: 1408-19. PMID 18036835 DOI: 10.1016/j.neuroimage.2007.10.016  1
2008 Salvatore E, Varrone A, Criscuolo C, Mancini P, Sansone V, Strisciuglio C, Cicala D, Scarano V, Salvatore M, Pappatà S, De Michele G, Filla A. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1. Journal of Neurology. 255: 45-8. PMID 18004640 DOI: 10.1007/s00415-007-0657-x  1
2008 Takano A, Halldin C, Varrone A, Karlsson P, Sjöholm N, Stubbs JB, Schou M, Airaksinen AJ, Tauscher J, Gulyás B. Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study. European Journal of Nuclear Medicine and Molecular Imaging. 35: 630-6. PMID 18000665 DOI: 10.1007/s00259-007-0622-z  1
2008 Takano A, Gulyás B, Varrone A, Karlsson P, Schou M, Airaksinen AJ, Vandenhende F, Tauscher J, Halldin C. Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2. European Journal of Nuclear Medicine and Molecular Imaging. 35: 153-7. PMID 17909794 DOI: 10.1007/s00259-007-0598-8  1
2007 de Leva MF, Varrone A, Filla A, Quarantelli M, Bilo L, Piscitelli V, Salvatore E, Ammendola S, Striano S, De Michele G, Bonavita V, Pappatà S. Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2117-21. PMID 17853478 DOI: 10.1002/mds.21711  1
2007 Varrone A, Pagani M, Salvatore E, Salmaso D, Sansone V, Amboni M, Nobili F, De Michele G, Filla A, Barone P, Pappatà S, Salvatore M. Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. European Journal of Nuclear Medicine and Molecular Imaging. 34: 1071-81. PMID 17245531 DOI: 10.1007/s00259-006-0344-7  1
2007 Pellecchia MT, Varrone A, Annesi G, Amboni M, Cicarelli G, Sansone V, Annesi F, Rocca FE, Vitale C, Pappatà S, Quattrone A, Barone P. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 559-63. PMID 17149727 DOI: 10.1002/mds.21262  1
2007 Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, Varrone A, Tatsch K. Reply [4] European Journal of Nuclear Medicine and Molecular Imaging. 34: 1133-1134. DOI: 10.1007/s00259-007-0408-3  1
2006 Del Giudice E, Bianchi MC, Tosetti M, Varrone A, Romano A, Crisanti AF, Titomanlio L, Imperati F. Taylor-type focal cortical dysplasia: is the epilepsy always resistant to medical treatment? Epileptic Disorders : International Epilepsy Journal With Videotape. 8: 289-93. PMID 17150443 DOI: 10.1684/epd.2006.0045  1
2006 Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, Varrone A, Tatsch K. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. European Journal of Nuclear Medicine and Molecular Imaging. 33: 1374-80. PMID 16932934 DOI: 10.1007/s00259-006-0206-3  1
2006 Seneca N, Gulyás B, Varrone A, Schou M, Airaksinen A, Tauscher J, Vandenhende F, Kielbasa W, Farde L, Innis RB, Halldin C. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology. 188: 119-27. PMID 16896954 DOI: 10.1007/s00213-006-0483-3  1
2006 Criscuolo C, Volpe G, De Rosa A, Varrone A, Marongiu R, Mancini P, Salvatore E, Dallapiccola B, Filla A, Valente EM, De Michele G. PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1265-7. PMID 16700027 DOI: 10.1002/mds.20933  1
2006 Cuocolo A, Acampa W, Varrone A, Salvatore M. Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care. European Journal of Nuclear Medicine and Molecular Imaging. 33: 360-81. PMID 16538466 DOI: 10.1007/s00259-006-1986-1  1
2006 Salvatore E, Varrone A, Sansone V, Nolano M, Bruni AC, De Rosa A, Santoro L, Pappatà S, Filla A, De Michele G. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 872-5. PMID 16532453 DOI: 10.1002/mds.20827  1
2006 Schou M, Pike VW, Varrone A, Gulyás B, Farde L, Halldin C. Synthesis and PET evaluation of (R)-[S-methyl-11C] thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters Journal of Labelled Compounds and Radiopharmaceuticals. 49: 1007-1019. DOI: 10.1002/jlcr.1128  1
2004 Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Neurology. 63: 2097-103. PMID 15596756  1
2004 Varrone A, Salvatore E, De Michele G, Barone P, Sansone V, Pellecchia MT, Castaldo I, Coppola G, Brunetti A, Salvatore M, Pappatà S, Filla A. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism. Annals of Neurology. 55: 426-30. PMID 14991822 DOI: 10.1002/ana.20054  1
2004 Fujita M, Varrone A, Kim KM, Watabe H, Zoghbi SS, Seneca N, Tipre D, Seibyl JP, Innis RB, Iida H. Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET. European Journal of Nuclear Medicine and Molecular Imaging. 31: 644-54. PMID 14730406 DOI: 10.1007/s00259-003-1431-7  1
2003 Kim KM, Varrone A, Watabe H, Shidahara M, Fujita M, Innis RB, Iida H. Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 512-9. PMID 12679393  1
2002 Varrone A, Pappatà S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1447-54. PMID 12397463 DOI: 10.1007/s00259-002-0883-5  1
2002 Kim KM, Watabe H, Varrone A, Fujita M, Innis RB, Iida H. Evaluation of Two Scatter Correction Methods in Quantitative Brain SPECT with Dopaminergic Tracer Ieee Nuclear Science Symposium and Medical Imaging Conference. 3: 1792-1796.  1
2001 Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 1023-32. PMID 11748733 DOI: 10.1002/mds.1256  1
2000 Pace L, Nappi A, Imbriaco M, Cuocolo A, Varrone A, Romano M, Trimarco B, Salvatore M. [Relationship between exercise capacity and left ventricular function at rest in patients with heart insufficiency: radionuclide continuous monitoring of left ventricular function]. La Radiologia Medica. 100: 120-5. PMID 11148876  1
2000 Varrone A, Fujita M, Verhoeff NP, Zoghbi SS, Baldwin RM, Rajeevan N, Charney DS, Seibyl JP, Innis RB. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 41: 1343-51. PMID 10945525  1
2000 Guadagni S, Pizzutilli A, Mancini E, Varrone A, Palumbo G, Amicucci G, Perri S, Deraco M, Fiorentini G. Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 26: 381-6. PMID 10873360 DOI: 10.1053/ejso.1999.0903  1
2000 Fujita M, Verhoeff NP, Varrone A, Zoghbi SS, Baldwin RM, Jatlow PA, Anderson GM, Seibyl JP, Innis RB. Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans. European Journal of Pharmacology. 387: 179-88. PMID 10650158 DOI: 10.1016/S0014-2999(99)00817-1  1
1999 Varrone A, Soricelli A, Postiglione A, Salvatore M. Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT. Clinical Nuclear Medicine. 24: 660-5. PMID 10478740 DOI: 10.1097/00003072-199909000-00004  1
1999 Nicolai E, Cuocolo A, Acampa W, Varrone A, Pace L, Salvatore M. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 6: 270-7. PMID 10385182 DOI: 10.1016/S1071-3581(99)90038-7  1
1998 Pace L, Perrone-Filardi P, Mainenti P, Cuocolo A, Vezzuto P, Prastaro M, Varrone A, De Luca G, Soricelli A, Betocchi S, Chiariello M, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: optimal image analysis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 1869-74. PMID 9829573  1
1998 Della Morte AM, Storto G, Varrone A, Pace L, Cuocolo A, Perrone-Filardi P, Betocchi S, Chiariello M, Salvatore M. [Effects left ventricle asynchrony on systolic and diastolic function in patients with non-ischemic heart failure]. La Radiologia Medica. 96: 68-72. PMID 9819621  1
1998 Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 5: 265-74. PMID 9669581 DOI: 10.1016/S1071-3581(98)90128-3  1
1998 Pace L, Perrone-Filardi P, Mainenti P, Prastaro M, Vezzuto P, Varrone A, Crisci T, Cuocolo A, Dellegrottaglie S, Piscione F, Chiariello M, Salvatore M. Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. European Journal of Nuclear Medicine. 25: 744-50. PMID 9662597 DOI: 10.1007/s002590050278  1
1998 Soricelli A, Cuocolo A, Varrone A, Discepolo A, Tedeschi E, Mainenti PP, Grivet-Fojaja MR, Covelli EM, Postiglione A, Salvatore M. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 802-6. PMID 9591579  1
1998 Pace L, Perrone-Filardi P, Mainenti PP, Prastaro M, Cuocolo A, Varrone A, Vezzuto P, Crisci T, Soricelli A, Piscione F, Chiariello M, Salvatore M. Effects of myocardial revascularization on regional thallium-201 uptake and systolic function in regions with reverse redistribution on tomographic thallium-201 imaging at rest in patients with chronic coronary artery disease. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 5: 153-60. PMID 9588667 DOI: 10.1016/S1071-3581(98)90198-2  1
1997 Nappi A, Cuocolo A, Imbriaco M, Nicolai E, Varrone A, Morisco C, Romano M, Trimarco B, Salvatore M. Ambulatory monitoring of left ventricular function: walk and bicycle exercise in congestive heart failure. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 948-53. PMID 9189148  1
1996 Soricelli A, Mainenti PP, Leone D, Discepolo A, Romano M, Varrone A, Servillo G, Serio S, Brunetti A, Salvatore M. Evaluation of brain perfusion with high resolution single photon emission tomography in the diagnosis of brain death. Minerva Anestesiologica. 62: 209-12. PMID 8937044  1
1996 Soricelli A, Postiglione A, Grivet-Fojaja MR, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen NA. Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses. European Journal of Nuclear Medicine. 23: 1323-8. PMID 8781136 DOI: 10.1007/BF01367587  1
1995 Gallo A, Feliciello A, Varrone A, Cerillo R, Gottesman ME, Avvedimento VE. Ki-ras oncogene interferes with the expression of cyclic AMP-dependent promoters. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 6: 91-5. PMID 7718489  1
Show low-probability matches.